Research map: Position Paper of the German Diabetes Association, German Society of Angiology and Vascular Medicine, German Society for Vascular Surgery and Vascular Medicine and German Society for Interventional Radiology and Minimally Invasive Therapy on the Diagnosis and Treatment of Peripheral Arterial Occlusive Disease in Diabetes Mellitus

Back to the article

Papers in this map

  1. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes · Bernard Zinman · 2015 · 12293 citations · Cited by this paper
  2. Responses of Regulator of G Protein Signaling Proteins and Circadian Clock Components to Sustained Depolarization-Induced Dedifferentiation in MIN6 β-Cells · 2025 · Related
  3. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes · Bruce Charles Neal · 2017 · 7911 citations · Cited by this paper
  4. Diabetic Foot Syndrome · 2025 · Related
  5. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes · Steven P. Marso · 2016 · 7637 citations · Cited by this paper
  6. Pilot study: transduction of primary paraganglioma chromaffin tumour cells with inducible c-MYC drives cell proliferation · 2026 · Related
  7. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes · Steven P. Marso · 2016 · 6910 citations · Cited by this paper
  8. Gestational Diabetes Mellitus (GDM), Diagnostics, Therapy and Follow-up Care · 2025 · Related
  9. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) · 1996 · 6561 citations · Cited by this paper
  10. Serum Carcinoembryonic Antigen, Carbohydrate Antigen, Neuron-specificEnolase and Lipid Profile to Predict the Occurrence, Pathological Grading andMetastasis of Pancreatic Neuroendocrine Tumors · 2026 · Related
  11. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes · Stephen D. Wiviott · 2018 · 6475 citations · Cited by this paper
  12. Diabetes and Pregnancy · 2025 · Related
  13. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy · Vlado Perkovic · 2019 · 6222 citations · Cited by this paper
  14. Diabetes Mellitus and the Heart · 2026 · Related
  15. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD · Francesco Cosentino · 2019 · 4927 citations · Cited by this paper
  16. Obesity and Diabetes · 2026 · Related
  17. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial · John Dormandy · 2005 · 4156 citations · Cited by this paper
  18. Acute Cold Exposure Improves Glucose Tolerance and Induces Beta-Cell Secretion Response Linked to Lipid Utilization in Young Male with Obesity · 2025 · Related
  19. Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes · Christoph Wanner · 2016 · 3687 citations · Cited by this paper
  20. Sudomotor Dysfunction in Fibrocalculous Pancreatic Diabetes: Clinical Insights From Electrochemical Skin Conductance Testing · 2026 · Related
  21. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis · F. Gerald R. Fowkes · 2013 · 3528 citations · Cited by this paper
  22. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial · Hertzel C. Gerstein · 2019 · 3179 citations · Cited by this paper
  23. Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes · Jennifer B. Green · 2015 · 2619 citations · Cited by this paper
  24. Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes · William B. White · 2013 · 2537 citations · Cited by this paper
  25. Global vascular guidelines on the management of chronic limb-threatening ischemia · Michael S. Conte · 2019 · 1978 citations · Cited by this paper
  26. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia, and foot Infection (WIfI) · Joseph L. Mills · 2013 · 1714 citations · Cited by this paper
  27. Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol · Kausik Kumar Ray · 2020 · 1658 citations · Cited by this paper
  28. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. · Abraham Michael Lincoff · 2007 · 1266 citations · Cited by this paper
  29. Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus · The ASCEND Study Collaborative Group · 2018 · 1188 citations · Cited by this paper
  30. Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly · John J. McNeil · 2018 · 1147 citations · Cited by this paper
  31. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack · Walter N. Kernan · 2016 · 1124 citations · Cited by this paper
  32. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases · Lucia Mazzolai · 2024 · 999 citations · Cited by this paper
  33. Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update) · Nicolaas C. Schaper · 2020 · 994 citations · Cited by this paper
  34. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients · Steven E. Nissen · 2023 · 957 citations · Cited by this paper
  35. Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia · Alik M. Farber · 2022 · 898 citations · Cited by this paper
  36. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial · Sonia S. Anand · 2017 · 891 citations · Cited by this paper
  37. Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease · Marc P. Bonaca · 2017 · 768 citations · Cited by this paper
  38. Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial · Faiez M. Zannad · 2015 · 759 citations · Cited by this paper
  39. Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease · William R. Hiatt · 2016 · 637 citations · Cited by this paper

Source: OpenAlex (CC0)